Becton, Dickinson and Company is an attractive firm that just made a good deal. Click here to find out why BDX stock is a Buy ...

Waters said it reached a deal to buy the Biosciences & Diagnostic Solutions business of Becton Dickinson for around $17.5 ...

Lab equipment maker Waters Corp on Monday said it will buy a bioscience and diagnostics unit spun off from medtech provider ...

Milford-based biotech company Waters Corp. will merge with Becton, Dickinson and Co.’s biosciences an diagnostic solutions ...

Shares of scientific instruments company Waters Corporation (NYSE:WAT) fell 12.8% in the morning session after the company ...

Becton Dickinson will spin off its biosciences and diagnostic business and merge it with Waters, and plans to use at least $2 ...

A deal for Becton Dickinson’s biosciences and diagnostic solutions unit puts Waters Corp. in a greater position to compete ...

Waters Corporation (WAT) stock downgraded at Wells Fargo based on execution risks related to its $17.5B M&A deal with a unit of Becton Dickinson (BDX). Read more here;.

Kirkland & Ellis advises Waters on $17.5B merger with Becton Dickinson, creating a diagnostics and life sciences leader.

Becton Dickinson’s plan to focus on medical technology advanced further after reaching a deal to divest its biosciences and diagnostic solutions business to Waters Corp. for around $17.5 billion.

Any one of the majors will be thrilled to snap some of these brands because there’s very little organic growth in the ...

Detailed price information for Becton Dickinson and Company (BDX-N) from The Globe and Mail including charting and trades.